Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 2, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Mustafa Dohadwala1, Fayak Kamili2, Na Mark Estes3
1North Texas Heart Center, Dallas, Texas.
No abstract available in PubMed .